Gilead's Kevin Young appointed Commander of the British Empire
This article was originally published in Scrip
Kevin Young, Gilead's executive vice-president of commercial operations, has been appointed a Commander of The British Empire in recognition of his "services to the healthcare and pharmaceutical industries, particularly to the development and marketing of life-changing medicines." The civilian honour comes after 28 years in the biotech and pharmaceutical sector. He joined Gilead in 2004 after working at companies including Amgen and AstraZeneca.